Is RYZB or JNJ a better dividend investment in 2026?

RYZB currently yields 3.20% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JNJ offers higher current income.

What is the dividend yield difference between RYZB and JNJ?

RYZB has a forward dividend yield of 3.20% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 0.16 percentage points.

Home › Compare › RYZB vs JNJ

RYZB vs JNJ: Dividend Comparison 2026

RYZB yields 3.20% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYZB wins by $4.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

RYZB

● Live price

3.20%

Share price

$62.49

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.6K

Annual income

$393.29

Full RYZB calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — RYZB vs JNJ

📍 RYZB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RYZB	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RYZB + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RYZB pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYZB

Annual income on $10K today (after 15% tax)

$272.04/yr

After 10yr DRIP, annual income (after tax)

$334.30/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $369.32/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYZB + JNJ for your $10,000?

RYZB: 50%JNJ: 50%

100% JNJ50/50100% RYZB

Portfolio after 10yr

$22.3K

Annual income

$610.54/yr

Blended yield

2.74%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RYZB

Analyst Ratings

Hold

Consensus: Hold

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYZB buys

JNJ buys

No recent congressional trades found for RYZB or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRYZBJNJ

Forward yield	3.20%	3.36% ✓
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$24.6K ✓	$20.0K
Annual income after 10y	$393.29	$827.78 ✓
Total dividends collected	$3.6K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: RYZB vs JNJ ($10,000, DRIP)

Year	RYZB Portfolio	RYZB Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,020	$320.05	$10,676	$355.77	+$344.00 → RYZB
2	$12,121	$329.62	$11,407	$389.39	+$714.00 → RYZB
3	$13,308	$338.84	$12,198	$426.53	+$1.1K → RYZB
4	$14,588	$347.69	$13,056	$467.62	+$1.5K → RYZB
5	$15,965	$356.18	$13,987	$513.12	+$2.0K → RYZB
6	$17,447	$364.31	$14,998	$563.56	+$2.4K → RYZB
7	$19,040	$372.08	$16,098	$619.52	+$2.9K → RYZB
8	$20,753	$379.49	$17,295	$681.69	+$3.5K → RYZB
9	$22,592	$386.56	$18,599	$750.82	+$4.0K → RYZB
10	$24,566	$393.29	$20,022	$827.78	+$4.5K → RYZB

RYZB vs JNJ: Complete Analysis 2026

RYZB — Stock

RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company’s lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California.

Full RYZB Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this RYZB vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYZB vs SCHD RYZB vs JEPI RYZB vs O RYZB vs KO RYZB vs MAIN RYZB vs ABBV RYZB vs MRK RYZB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.